SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
复制标题
DOI:
10.1016/j.celrep.2021.109055
复制
发表时间:
2021-05-04
期刊:
影响因子:
8.8
通讯作者:
Stripp BR
中科院分区:
文献类型:
--
作者:
Mulay A;Konda B;Garcia G Jr;Yao C;Beil S;Villalba JM;Koziol C;Sen C;Purkayastha A;Kolls JK;Pociask DA;Pessina P;de Aja JS;Garcia-de-Alba C;Kim CF;Gomperts B;Arumugaswami V;Stripp BR
Coronavirus disease 2019 (COVID-19) is the latest respiratory pandemic caused by severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2). Although infection initiates in the proximal airways, severe and sometimes fatal symptoms of the disease are caused by infection of the alveolar type 2 (AT2) cells of the distal lung and associated inflammation. In this study, we develop primary human lung epithelial infection models to understand initial responses of proximal and distal lung epithelium to SARS-CoV-2 infection. Differentiated air-liquid interface (ALI) cultures of proximal airway epithelium and alveosphere cultures of distal lung AT2 cells are readily infected by SARS-CoV-2, leading to an epithelial cell-autonomous proinflammatory response with increased expression of interferon signaling genes. Studies to validate the efficacy of selected candidate COVID-19 drugs confirm that remdesivir strongly suppresses viral infection/replication. We provide a relevant platform for study of COVID-19 pathobiology and for rapid drug screening against SARS-CoV-2 and emergent respiratory pathogens. In vitro models of human lung epithelium, including diverse cell types of the proximo-distal axis, are critical for modeling infection. Mulay et al. show that alveospheres, with epithelial type 2- and type 1-like cells, are infected by SARS-CoV-2, initiating an interferon response, and serve as a platform for screening antiviral drugs.
登录
查看更多内容
影响因子:
64.5
作者:
Hou, Yixuan J.;Okuda, Kenichi;Baric, Ralph S.
通讯作者:
Baric, Ralph S.
影响因子:
1.2
作者:
Konda, Bindu;Mulay, Apoorva;Stripp, Barry R.
通讯作者:
Stripp, Barry R.
影响因子:
23.9
作者:
Katsura H;Sontake V;Tata A;Kobayashi Y;Edwards CE;Heaton BE;Konkimalla A;Asakura T;Mikami Y;Fritch EJ;Lee PJ;Heaton NS;Boucher RC;Randell SH;Baric RS;Tata PR
通讯作者:
Tata PR
影响因子:
56.9
作者:
Lamers, Mart M.;Beumer, Joep;Clevers, Hans
通讯作者:
Clevers, Hans
影响因子:
82.9
作者:
Sungnak W;Huang N;Bécavin C;Berg M;Queen R;Litvinukova M;Talavera-López C;Maatz H;Reichart D;Sampaziotis F;Worlock KB;Yoshida M;Barnes JL;HCA Lung Biological Network
通讯作者:
HCA Lung Biological Network